investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Functional and Molecular Dissection of Myeloproliferative Neoplasm Stem Cells
Ann Mullally
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Ann Mullally
Brigham and Women's Hospital
Boston, United States
Related projects
Dongsu Park
Role of osteogenic stem cells in bone regeneration and repair in vivo
Leukaemia
Kimberly Stegmaier
Validating Syk as a Target for AML Therapy
Leukaemia
Xuefang Cao
Targeting Granzyme B to Separate GVH from GVL Responses
Leukaemia
Benjamin Levine Ebert
Development of Novel Therapeutic Strategies in Human Leukemias
Leukaemia
Alan Rein
Retrovirus Assembly And Maturation
Leukaemia
Pathology
Hematology and hematologic malignancies
Margaret A Goodell
Regulation of Hematopoietic Progenitors by de novo DNA Methylation
Leukaemia
Luca Gattinoni
Programming T Cell Fates for Therapeutic Use
Leukaemia
Pathology
Hematology and hematologic malignancies
Ronen Marmorstein
Structure and Function of Protein Acetyltransferases
Leukaemia
Yves Pommier
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
Leukaemia